Freight News, Logistics

GEODIS Expands UK Pharma Cold-chain Footprint

[ May 11, 2026   //   Gary Burrows ]

French logistics provider GEODIS is set to open a temperature-controlled pharmaceutical warehouse near Manchester Airport on June 1, targeting growing demand for compliant healthcare logistics in the UK and Ireland.

The facility will provide capacity for 2,000 pallets and support both inventory management and cross-docking of temperature-sensitive products. It includes controlled room temperature zones (15 to 25°C) and chilled storage (2 to 8°C), with the option to add frozen capability, alongside dedicated returns areas and continuous monitoring systems.

GEODIS said the site is compliant with Good Distribution Practice (GDP) requirements and supported by a validated warehouse management system enabling batch traceability, audit trails and real-time inventory visibility. The location, near the M6 and M62 corridors, is designed to support nationwide distribution while leveraging airfreight connectivity through Manchester.

The move reflects continued investment by logistics providers in healthcare supply chains, where regulatory compliance and temperature control are critical differentiators. Demand has remained elevated post-pandemic as pharmaceutical and biotech companies diversify distribution networks and build resilience into cold-chain capacity.

From a market standpoint, the UK has become an increasingly competitive hub for pharma logistics, with operators expanding regional facilities to reduce reliance on London-centric distribution and improve transit times. Manchester, in particular, has attracted attention due to its proximity to life sciences clusters in northern England and its multimodal connectivity.

For GEODIS, the site strengthens its contract logistics and healthcare vertical in a segment that typically offers higher margins but requires sustained capital investment and strict compliance oversight. The inclusion of multiple ISO certifications and security standards signals a push to meet the stringent requirements of pharmaceutical clients, particularly around product integrity and auditability.

More broadly, the expansion underscores a structural shift in logistics strategy: rather than centralizing inventory in large national hubs, shippers are increasingly deploying distributed, temperature-controlled nodes to balance speed, risk and regulatory compliance across supply chains.

Tags: Geodis